Changeflow GovPing Pharma & Drug Safety Inova Diagnostics Aptiva CTD Essential Controls...
Priority review Enforcement Amended Final

Inova Diagnostics Aptiva CTD Essential Controls Safety Action

Favicon for ansm.sante.fr ANSM Drug & Device Safety Alerts
Filed
Detected
Email

Summary

ANSM published safety alert R2608798 informing medical biology laboratories of a quality control recall by Inova Diagnostics for Aptiva CTD Essential Controls used in autoimmune testing. The manufacturer's safety action letter was distributed to affected users on 14 April 2026. Laboratories should review the recalled controls and contact Inova Diagnostics directly for guidance.

Published by ANSM on ansm.sante.fr . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

ANSM has published safety alert R2608798 regarding a quality control recall by Inova Diagnostics for Aptiva CTD Essential Controls. These are control materials used with the Aptiva instrument system for autoimmune disease testing. The manufacturer has initiated a safety action and issued a letter to affected laboratory users.\n\nMedical biology laboratories using Aptiva CTD Essential Controls should review the manufacturer's safety letter, assess the impact on their testing operations, and contact Inova Diagnostics directly for replacement or corrective measures. The recall affects the quality control materials used to verify test system performance in autoimmune diagnostics.

What to do next

  1. Review ANSM safety alert R2608798
  2. Consult Inova Diagnostics safety letter dated 14/04/2026
  3. Contact Inova Diagnostics for guidance on affected controls

Archived snapshot

Apr 14, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

A+ A-

Information n° R2608798 destinée aux laboratoires d'analyses de biologie médicale L'ANSM a été informée de la mise en œuvre d’une action de sécurité effectuée par la société Inova Diagnostics.
Les utilisateurs concernés ont reçu le courrier ci-joint.

Cette action de sécurité est enregistrée à l’ANSM sous le n° R2608798.
Pour toute question, merci de vous adresser directement à l’émetteur de l’action de sécurité. Consultez le courrier de la société Inova Diagnostics (14/04/2026)

Named provisions

Autoimmunity Control Quality Control Aptiva CTD Essential Controls

Get daily alerts for ANSM Drug & Device Safety Alerts

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from ANSM.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
ANSM
Filed
April 14th, 2026
Instrument
Enforcement
Legal weight
Binding
Stage
Final
Change scope
Substantive
Document ID
R2608798

Who this affects

Applies to
Healthcare providers Medical device makers Patients
Industry sector
3345 Medical Device Manufacturing
Activity scope
Medical device recall Quality control testing Autoimmune diagnostics
Geographic scope
France FR

Taxonomy

Primary area
Medical Devices
Operational domain
Clinical Operations
Compliance frameworks
GxP
Topics
Healthcare Pharmaceuticals Public Health

Get alerts for this source

We'll email you when ANSM Drug & Device Safety Alerts publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!